InterMune's rally pushes biotech index higher
March 05, 2010 at 10:43 AM EST
A rally in shares of InterMune marks the early action in biotech stocks, while an upgrade boosts Bristol-Myers Squibb among the drugmakers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.